Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chaiyin granules is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of influenza and other upper respiratory tract infections. It is specifically indicated for patients presenting with exogenous wind-heat syndrome, characterized by symptoms such as fever, sore throat, and cough. The formulation is derived from a combination of herbal extracts, most notably *Bupleurum chinense* (Chaihu) and *Lonicera japonica* (Jinyinhua), which are recognized in TCM for their antipyretic, anti-inflammatory, and antiviral properties. Clinical research, including multicenter trials sponsored by the China-Japan Friendship Hospital, has focused on evaluating its efficacy in reducing fever duration and symptom severity compared to standard antiviral treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chaiyin granules.